Paclitaxel-based chemotherapy for patients with refractory or relapsed nonseminomatous germ cell tumors

By Amato R.J.   Prow D.M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 5, Iss. 4, 2000-07 ,pp. : 134-138

Elsevier

Access to resources Recommend Favorite

Rapidly Recycled, Intensive Alternating Chemotherapy in Heavily Pretreated Progressive Nonseminomatous Germ Cell Tumors - A Feasibility Study

By Culine S.   Droz J.P.   Delva R.   Bui B.   Caty A.   Minier B.   Mital P.   Mousseau M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 1, Iss. 3, 1995-05 ,pp. : 109-114

Elsevier

Access to resources Recommend Favorite

Chemotherapy in Stage II Nonseminomatous Germ Cell Tumors of the Testis: The Institut Gustave Roussy Experience

By Culine S.   Theodore C.   Terrier-Lacombe M.J.   Droz J.-P.  

Urologic Oncology: Seminars and Original Investigations, Vol. 1, Iss. 5, 1995-09 ,pp. : 175-183

Elsevier

Access to resources Recommend Favorite

Prognostic Significance of Marker Half-life during Chemotherapy in Non-seminomatous Germ Cell Testicular Tumors

By İnanç Sevil E.   Meral Rasim   Darendeliler Emin   Yasasever Vildan   Onat Haluk  

Acta Oncologica, Vol. 38, Iss. 4, 1999-05 ,pp. : 505-509

Informa Healthcare

Access to resources Recommend Favorite

Treatment outcome of patients with extragonadal nonseminomatous germ cell tumors: the Saitama Cancer Center experience

By Fukui Naotaka   Kohno Yusuke   Ishioka Jun-Ichiro   Fukuda Hiroshi   Kageyama Yukio   Higashi Yotsuo  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 731-734

Springer Publishing Company

Access to resources Recommend Favorite